STOCK TITAN

Editas Medicine to Host Conference Call Discussing Third Quarter 2020 Results and Corporate Update

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Editas Medicine, a leading genome editing company, announced a conference call and webcast on November 5, 2020, at 5:00 PM ET to discuss its third-quarter results and corporate updates. Investors can access the call by dialing (844) 348-3801 domestically or (213) 358-0955 internationally. The conference ID is 9992536. A live webcast will be available on the Editas Medicine website.

Editas focuses on developing transformative genomic medicines using CRISPR technology.

Positive
  • None.
Negative
  • None.

CAMBRIDGE, Mass., Oct. 29, 2020 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a leading genome editing company, today announced that it will host a conference call and webcast on Thursday, November 5, 2020, at 5:00 p.m. ET to discuss a corporate update and results for the third quarter of 2020.

Conference Call & Webcast Details 
Date:Thursday, November 5, 2020
Time:5:00 pm Eastern Time
Toll Free:(844) 348-3801
International:(213) 358-0955
Conference ID:9992536
Webcast:https://edge.media-server.com/mmc/p/b5td2coz

A live webcast of the conference call can be accessed in the Investors section of Editas Medicine website at https://www.editasmedicine.com/.

About Editas Medicine
As a leading genome editing company, Editas Medicine is focused on translating the power and potential of the CRISPR/Cas9 and CRISPR/Cas12a (also known as Cpf1) genome editing systems into a robust pipeline of treatments for people living with serious diseases around the world. Editas Medicine aims to discover, develop, manufacture, and commercialize transformative, durable, precision genomic medicines for a broad class of diseases. For the latest information and scientific presentations, please visit www.editasmedicine.com.

Contacts:
Investors
Mark Mullikin
(617) 401-9083
mark.mullikin@editasmed.com 

Media
Cristi Barnett
(617) 401-0113
cristi.barnett@editasmed.com 

FAQ

What date is the Editas Medicine conference call?

The Editas Medicine conference call is scheduled for November 5, 2020.

What time will the Editas Medicine conference call take place?

The conference call will take place at 5:00 PM ET.

How can I listen to the Editas Medicine conference call?

You can listen to the call by calling (844) 348-3801 for domestic lines or (213) 358-0955 for international calls, using conference ID 9992536.

Where can I find the webcast of the Editas Medicine conference call?

The live webcast will be available on the Editas Medicine website.

What is the focus of Editas Medicine?

Editas Medicine focuses on developing genomic medicines using CRISPR/Cas9 and Cas12a technologies.

Editas Medicine, Inc.

NASDAQ:EDIT

EDIT Rankings

EDIT Latest News

EDIT Stock Data

203.89M
82.28M
0.32%
70.13%
20.88%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States of America
CAMBRIDGE